-
Mashup Score: 0
Irritable bowel syndrome (IBS) is a gut-brain pain disorder that is classified according to bowel habits, even though non-gastrointestinal factors may influence clinical course and outcomes. In light of this discrepancy, Madhusudan Grover, MD, of the Mayo Clinic in Rochester, Minnesota, and colleagues conducted a survey-based case-control study to determine if IBS patients cluster according to various parameters, including clinical, dietary, lifestyle, and psychosocial factors.
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 3
Colitis-associated colorectal carcinoma (CAC) occurs in inflammatory bowel disease (IBD) because of the “chronic inflammation-dysplasia-cancer” carcinogenesis pathway characterized by p53 alterations in the early stages. Recently, gastric metaplasia (GM) has been described as the initial event of the serrated colorectal cancer (CRC) process, resulting from chronic stress on the colon mucosa. The…
Source: MDPICategories: Future of Medicine, Latest HeadlinesTweet-
Contributing to molecularly characterize the #colorectalcancer associated to #Inflammatory #Bowel #Disease #IBD, article led by Dr Eva Musulen in @IJMS_MDPI https://t.co/BqAijWgOCo https://t.co/xlzmHiczlu
-
-
Mashup Score: 6Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer - 11 month(s) ago
Single- and double-faecal immunochemical test (FIT) strategies were tested in high-risk symptomatic patients. A double-FIT strategy reduced missed colorectal ca
Source: OUP AcademicCategories: General Medicine News, Latest HeadlinesTweet-
Double testing better at identifying #bowel #cancer https://t.co/GIvDEtecxS https://t.co/Cniwv8JkvX
-
-
Mashup Score: 3
Fresh insights into how our bodies interact with the microbes living in our guts suggest that a two-drug combination may offer a new way to treat inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis.
Source: EurekAlert!Categories: General Medicine News, Latest HeadlinesTweet-
Fresh insights into how our bodies interact with the #microbes living in our #guts suggest that a two-drug combination may offer a new way to treat #inflammatory #bowel #diseases such as #Crohn’s disease and ulcerative colitis @CincyChildrens https://t.co/jArhSB2C0L
-
-
Mashup Score: 0IBS Patients Don't Fit Into a One-Size-Fits-All Model - 1 year(s) ago
Dietary, psychiatric factors can be considered when patients are grouped into different clusters
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: This pattern is further propagated in #IBS treatment, with FDA-approved drugs only targeting pain and #bowel dysfunction. @AmerGastroAssn #gastroenterology Read more: https://t.co/hN8iRPnYbG https://t.co/smQswLRA5k
-
-
Mashup Score: 0
With rates rising rapidly, policymakers should plan for increased demand on healthcare resources
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
What was known about prevalence and outcomes across the different age groups affected by early-onset inflammatory #bowel disease (#IBD)? @AmerGastroAssn #gastroenterology Read more: https://t.co/K6XXTIjAzn https://t.co/ZMq2Jjfk5i
-
-
Mashup Score: 4VIDEO: Mirikizumab induces ‘rapid control’ of bowel urgency, symptomatic remission in UC - 2 year(s) ago
VIENNA — In a Healio video exclusive, Maria T. Abreu, MD, reported mirikizumab induced “rapid control” of bowel movement urgency and fatigue among patients with mild to moderate ulcerative colitis. Specifically, compared with placebo, patients treated with mirikizumab had improved rectal bleeding (approx. 64% vs. 43%), stool frequency (60% vs. 40%) and bowel urgency (22% vs.
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
In a Healio video exclusive, @ibddocmaria reported #mirikizumab induced “rapid control” of #bowel movement urgency and #fatigue among patients with mild to moderate #ulcerativecolitis @my_ueg #UEGWeek #UC #IBD #GITwitter #MedTwitter https://t.co/hEqWe3aruX
-
-
Mashup Score: 2Upadacitinib improves abdominal pain, bowel urgency in UC - 2 year(s) ago
Upadacitinib induced sustained improvements in abdominal pain, bowel urgency and fatigue in patients with moderate to severe ulcerative colitis, according to research presented at ECCO.
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI from #ECCO2022: #Upadacitinib improves #abdominalpain, #bowel urgency in #UC #GITwitter #MedTwitter https://t.co/M41ZyqV5wh
-
-
Mashup Score: 0Upadacitinib improves abdominal pain, bowel urgency in UC - 2 year(s) ago
Upadacitinib induced sustained improvements in abdominal pain, bowel urgency and fatigue in patients with moderate to severe ulcerative colitis, according to research presented at ECCO.
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#Upadacitinib induced sustained improvements in #abdominalpain, #bowel urgency and #fatigue in patients with moderate to severe #ulcerativecolitis #ECCO2022 https://t.co/M41ZyqV5wh
-
-
Mashup Score: 2Chronic granulomatous disease with inflammatory bowel disease: Clinical presentation, treatment, and outcomes from the USIDNET Registry - 2 year(s) ago
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by defects in the phagocytic NADPH oxidase complex, leading to increased susceptibility to infection and inflammatory autoimmune diseases. Up to 50% of patients have gastrointestinal (GI) involvement and meet diagnostic criteria for inflammatory bowel disease (CGD-IBD).
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! #Chronic #granulomatous #disease with #inflammatory #bowel #disease: Clinical presentation, treatment, and outcomes from the #USIDNET Registry https://t.co/KHMFndData
-
ICYMI: Why did your group feel it was important to look beyond the strictly #bowel-related classifications among #irritable bowel syndrome patients? #AGAReadingRoom @AmerGastroAssn #Gastroenterology Read more: https://t.co/ZJ9NTak66U https://t.co/3rlqojGo1F